((2R,3S,5R)-5-(5-Fluoro-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate

Catalog No. :
ACCWWC144
CAS No. :
114333-22-1
Molecular Formula :
C9H13FN3O8P
Molecular Weight :
341.19

IUPAC Name:((2R,3S,5R)-5-(5-fluoro-4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate

((2R,3S,5R)-5-(5-Fluoro-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((2R,3S,5R)-5-(5-Fluoro-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
IUPAC Name((2R,3S,5R)-5-(5-fluoro-4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
Molecular FormulaC9H13FN3O8P
Molecular Weight341.19
SMILESO=P(O)(OC[C@H]1O[C@@H](N(C(N/2)=O)C=C(F)C2=N\O)C[C@@H]1O)O
InChI KeyNLJQYFRLORVALI-RRKCRQDMSA-N
SynonymN(4)-hydroxy-5-fluorodeoxycytidine monophosphate;5'-Uridylic acid, 2'-deoxy-5-fluoro-, 4-oxime (9CI);N(4)-HYDROXY-5-FLUORODEOXYCYTIDINE MONOPHOSPHONATE
CAS No.114333-22-1

Synthetic Route by SureRoute

1. ACCWWC144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCWWC144 route product structure diagram
    ACCWWC144114333-22-1
Inquiry

2. ACCWWC144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCWWC144 route product structure diagram
    ACCWWC144114333-22-1
Inquiry

Comments (0)